ArticleFrontiers in oncology2023

Dose outside of the prostate is associated with improved outcomes for high-risk prostate cancer patients treated with brachytherapy boost.

Jane Shortall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.